Search details
1.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
N Engl J Med
; 386(23): 2188-2200, 2022 06 09.
Article
in English
| MEDLINE | ID: mdl-35443106
2.
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
Clin Infect Dis
; 76(7): 1247-1256, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36411267
3.
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Infect Dis Ther
; 13(6): 1253-1268, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38703336
4.
Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
Infect Immun
; 70(2): 692-701, 2002 Feb.
Article
in English
| MEDLINE | ID: mdl-11796601
Results
1 -
4
de 4
1
Next >
>>